eClinical Solutions Releases Newest Version of elluminate®
eClinical Solutions, LLC, a leading provider of data management services and technologies, today announced the release of elluminate®.
eClinical Solutions, a provider of data management services and technologies, announced the release of the latest version of its end to end clinical data repository and analytics platform, elluminate®. The elluminate® platform integrates and standardizes clinical and operational data, regardless of source, to enable advanced analytics and adhoc reporting capabilities. This release enhances the ability to visualize operational data such as metrics, audit trail, and queries to support risk based monitoring and site management. The release also enhances the ability to define workflows to support advanced data integrations. Read the full text here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Arcus’ Quemliclustat Earns Orphan Drug Designation as Phase III Pancreatic Cancer Trial Advances
July 11th 2025The FDA has granted orphan status to Arcus Biosciences’ CD73 inhibitor quemliclustat for metastatic pancreatic cancer, as the global PRISM-1 Phase III trial nears full enrollment following promising survival data from ARC-8.
QWINT-1 Trial: Once-Weekly Efsitora Matches Daily Glargine in Type 2 Diabetes Management
July 10th 2025Results from the Phase III QWINT-1 trial show that Eli Lilly’s once-weekly insulin efsitora is noninferior to once-daily glargine in reducing HbA1c among insulin-naïve adults with type 2 diabetes, offering a simplified fixed-dose regimen with fewer hypoglycemic events and less treatment burden.
